Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Syra Health Corp publishes a filing, an earnings call transcript or a press release.

Get SYRA alerts

About Priya Prasad

Priya Prasad is recorded as CFO, Board Member and CEO at Syra Health Corp (SYRA). The newest filing on record that lists Priya Prasad as CFO and Board Member at Syra Health Corp (SYRA) is dated June 1, 2026. The newest filing on record that lists Priya Prasad as CEO at Syra Health Corp (SYRA) is dated September 19, 2025. Syra Health Corp reported in an 8-K filed June 17, 2025 that Priya Prasad was appointed interim CEO, effective June 16, 2025. Syra Health Corp reported in an 8-K filed March 28, 2024 that Priya Prasad was appointed director, effective March 27, 2024. The proxy statement of Syra Health Corp reports total compensation of $272,964 for Priya Prasad in fiscal 2025, including a base salary of $265,384. Disclosed compensation is on record for 4 fiscal years. Priya Prasad has spoken on 4 earnings calls across 1 company, most recently for Syra Health Corp on May 8, 2025. Syra Health Corp is classified in the Medical Care Facilities industry within the Healthcare sector. Other leadership on record at Syra Health Corp includes Gregory R. Alexander (CEO), Sandeep Allam (Chairman), Andrew Dahlem (Board Member) and 6 others.

“On June 16, 2025, the Board of Directors of the Company appointed Priya Prasad, the Company's CFO and COO, as interim CEO.”
Syra Health Corp Form 8-K, filed June 17, 2025 · Read the filing
“On March 27, 2024, the Board of Directors of Syra Health Corp. (the "Company") appointed Priya Prasad, the Company's COO and CFO as a director of the Company.”
Syra Health Corp Form 8-K, filed March 28, 2024 · Read the filing

Priya Prasad on recent calls

“The financial results for the first quarter of 2025 are provided in detail within our press release, which we issued earlier this morning and in our 10-Q. Before I get started, I would like to provide a housekeeping item related to the reporting of our business units.”
CFO, Syra Health Corp Q1 FY2025 Earnings Call ·
“The financial results for the fourth quarter and full year of 2024 are provided in detail within our press release, which we issued earlier this morning and in our 10-K. Total revenues for 2024 were $8 million compared to $5.5 million in 2023, representing a year-over-year growth of 45%.”
CFO, Syra Health Corp Q4 FY2024 Earnings Call ·
“The financial results for the full year are provided in detail within our press release, which was issued earlier this morning and in our 10-Q. Total revenue for the first quarter of 2024 was $1.7 million compared to $1.2 million in the first quarter of last year, representing a 47% growth.”
CFO, Syra Health Corp Q1 FY2024 Earnings Call ·
“The financial results for the full year are provided in detail within our 10-K, as well as within our press release, which we issued earlier this morning. For the full year, 2023 revenues were $5.5 million compared to $5.6 million in 2022, representing a 2% decline.”
CFO, Syra Health Corp Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Syra Health Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Syra Health Corp (SYRA) $265,384 $272,964
2024 Syra Health Corp (SYRA) $164,703 $171,291
2023 Syra Health Corp (SYRA) $147,115 $153,250
2022 Syra Health Corp (SYRA) $119,568 $122,235

Recent activity